Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P8
Near historical low
vs 3Y Ago
-6.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -29.68% |
| 2024 | 76.33% |
| 2023 | 24.23% |
| 2022 | 4.32% |
| 2021 | 15.12% |
| 2020 | -17.36% |
| 2019 | 117.43% |
| 2018 | 119.87% |
| 2017 | 16.84% |
| 2016 | 174.12% |